Related Experiment Video
Updated: Jan 9, 2026

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
Published on: January 17, 2014
An Integrated Data-Driven Model for Clinical Phenotyping of Tuberculosis Disease Severity
Samantha Malatesta1, Karen R Jacobson2, C Robert Horsburgh1,2,3
1Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
None:
A common approach to describing tuberculosis (TB) disease severity is to use a binary classification such as "advanced" and "minimal or early disease," though this may not fully capture the range of clinical presentations. As individuals transition through stages of disease, we expect to observe increased bacterial burden and inflammation which corresponds to worsening disease severity and increased risk of a negative outcome. We develop a new method, tuberculosis SeveriTy Assessment Tool for Informed Stratification (TB-STATIS), to understand the various disease severity phenotypes that exist at time of clinical presentation. Our method integrates data from multiple sources (i.e. smear microscopy, chest x-ray findings, symptoms, etc.) to identify a set of disease severity classes and obtain a predicted disease class for each individual given their observed data. Our approach is motivated by the statistical framework used in event-based modeling, a type of data-driven disease progression modeling. We show in simulation TB-STATIS can correctly identify the true set of disease classes with various sample sizes, data sources to integrate, and levels of uncertainty in the observed data. We apply TB-STATIS to two data sets, data from an observational TB cohort in South Africa and data from a global phase 3 clinical trial that tested the non-inferiority of two 4-month regimens compared to the standard 6-month regimen for the treatment of TB. We observe disease classes generated from TB-STATIS correlate with culture conversion, a proxy for TB treatment response. We demonstrate our approach to classifying TB disease severity generates clinically meaningful strata.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...

